IL-6 is increased in the CSF of other inflammatory neurological disorders including transverse myelitis (TM) and neuromyelitis optica (NMO) [118, 119], in the lesions of MS patients [120], and in some cases, correlates with relapse or general neurodegeneration in the progressive phase [121]. The gene discussed is IL6; the disease is neuromyelitis optica.